Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Wachter, David L."'
Autor:
Strehl, Johanna D., Wachter, David L., Fiedler, Jutta, Heimerl, Engelbert, Beckmann, Matthias W., Hartmann, Arndt, Agaimy, Abbas
Publikováno v:
In Annals of Diagnostic Pathology August 2015 19(4):198-202
Autor:
Goertz, Ruediger S., Sturm, Joerg, Pfeifer, Lukas, Wildner, Dane, Wachter, David L., Neurath, Markus F., Strobel, Deike
Publikováno v:
In Annals of Hepatology November-December 2013 12(6):935-941
Autor:
Anton, Gisela, Bayer, Florian, Beckmann, Matthias W., Durst, Jürgen, Fasching, Peter A., Haas, Wilhelm, Hartmann, Arndt, Michel, Thilo, Pelzer, Georg, Radicke, Marcus, Rauh, Claudia, Rieger, Jens, Ritter, André, Schulz-Wendtland, Rüdiger, Uder, Michael, Wachter, David L., Weber, Thomas, Wenkel, Evelyn, Wucherer, Lukas
Publikováno v:
In Zeitschrift für Medizinische Physik September 2013 23(3):228-235
Autor:
Michal, Michal, Kazakov, Dmitry V., Kacerovska, Denisa, Kuroda, Naoto, Lovric, Eva, Wachter, David L., Agaimy, Abbas, Hes, Ondrej
Publikováno v:
In Annals of Diagnostic Pathology April 2013 17(2):151-158
Autor:
Wachter, David L.1 davidwachter@gmail.com, Wachter, Peter W.1, Fasching, Peter A.2, Beckmann, Matthias W.2, Hack, Carolin C.2, Riener, Marc-Oliver3, Hartmann, Arndt1, Strehl, Johanna D.1
Publikováno v:
Archives of Pathology & Laboratory Medicine. Feb2019, Vol. 143 Issue 2, p206-211. 6p. 3 Color Photographs, 1 Diagram, 1 Graph.
Autor:
Emons, Julius, Fasching, Peter A., Wunderle, Marius, Heindl, Felix, Rieger, Jens, Horn, Florian, Pelzer, Georg, Ritter, Andre, Weber, Thomas, Radicke, Marcus, Polifka, Iris, Wachter, David L., Wenkel, Evelyn, Michel, Thilo, Uder, Michael, Hartmann, Arndt, Anton, Gisela, Beckmann, Matthias W., Schulz-Wendtland, Rüdiger, Jud, Sebastian M.
Supplemental material, REV1_Supplementary_figures2 for Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup by Julius Emons, Peter A. Fasching, Marius Wunderle, Felix Heindl, Jens Rieger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a22801d98b098eecaf7b186befa812e
Autor:
Emons, Julius, Fasching, Peter A., Wunderle, Marius, Heindl, Felix, Rieger, Jens, Horn, Florian, Pelzer, Georg, Ritter, Andre, Weber, Thomas, Radicke, Marcus, Polifka, Iris, Wachter, David L., Wenkel, Evelyn, Michel, Thilo, Uder, Michael, Hartmann, Arndt, Anton, Gisela, Beckmann, Matthias W., Schulz-Wendtland, Rüdiger, Jud, Sebastian M.
Supplemental material, PAPER_0306_BD14_V7_clean._Suplementary_Data_Tabellen for Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup by Julius Emons, Peter A. Fasching, Marius Wunderle,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b91b140a051b912da59e283be227332
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gass, Paul, Lux, Michael P., Rauh, Claudia, Hein, Alexander, Bani, Mayada R., Fiessler, Cornelia, Hartmann, Arndt, Häberle, Lothar, Pretscher, Jutta, Erber, Ramona, Wachter, David L., Schulz-Wendtland, Rüdiger, Beckmann, Matthias W., Fasching, Peter A., Wunderle, Marius
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Background It has been reported that pathological complete response is an important surrogate marker for disease-free survival and overall survival in patients with triple-negative breast cancer. This study investigates predictors of the response to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7e111c8f00bddf434e98b58ff0a20778
http://europepmc.org/articles/PMC6206705
http://europepmc.org/articles/PMC6206705
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Autor:
Fasching Peter A, Heusinger Katharina, Haeberle Lothar, Niklos Melitta, Hein Alexander, Bayer Christian M, Rauh Claudia, Schulz-Wendtland Ruediger, Bani Mayada R, Schrauder Michael, Kahmann Laura, Lux Michael P, Strehl Johanna D, Hartmann Arndt, Dimmler Arno, Beckmann Matthias W, Wachter David L
Publikováno v:
BMC Cancer, Vol 11, Iss 1, p 486 (2011)
Abstract Background The pathological complete response (pCR) after neoadjuvant chemotherapy is a surrogate marker for a favorable prognosis in breast cancer patients. Factors capable of predicting a pCR, such as the proliferation marker Ki67, may the
Externí odkaz:
https://doaj.org/article/502052e4eedd44c1beb13b9874488087